Giloralimab (Anti-TNFRSF5 / CD40)

Giloralimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody directed against the B-cell surface antigen CD40 with potential antineoplastic activity. MW: 145.26 KD.

• Supplier: Selleck Chemicals
• Product #: A2884
• Sku #: A2884-1mg*25